Ikarian Capital, LLC
DALLAS, TX · CIK 1778253 · 13F filing filed 2020-01-31
SEC-registered investment adviser since 2020 · limited liability company
- Assets managed$698.0m
- Staff8 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $564.0m gross assets
- Form ADV · 2026-05-20SEC adviser record
- Legal entityIKARIAN CAPITAL, LLC (US)
- Kindhedge funds, futures
- Others nearbyDallas, TX
As an employer
- Offices in1 country
- Private fundshedge 1
$108.7m
reported value
53positions
54.4%in top 10
—no comparable previous quarter
Options: 37 call positions ($212.7m notional), 24 put positions ($295.8m notional) – listed below, not included above.
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| INTERCEPT PHARMACEUTICALS IN ICPT · Put | $93.5m754.9k shares | — |
| SPDR SER TR XBI · Put | $33.3m350.0k shares | — |
| GILEAD SCIENCES INC GILD · Call | $32.5m500.0k shares | — |
| INTRA-CELLULAR THERAPIES INC ITCI · Put | $31.7m924.1k shares | — |
| ISHARES TR IBB · Put | $30.1m250.0k shares | — |
| ALLAKOS INC ALLKG · Call | $15.1m158.8k shares | — |
| SAREPTA THERAPEUTICS INC SRPT · Call | $13.2m102.6k shares | — |
| MIRATI THERAPEUTICS INC MRTX · Call | $12.9m100.0k shares | — |
| BEIGENE LTD ONC · Put | $12.8m77.0k shares | — |
| GOSSAMER BIO INC GOSS · Put | $12.1m771.1k shares | — |
| BIOHAVEN PHARMACTL HLDG CO L BHVN · Call | $10.9m200.0k shares | — |
| GW PHARMACEUTICALS PLC GWPH · Call | $10.5m100.0k shares | — |
| ARQULE INC ARQL · Call | $9.9m497.7k shares | — |
| ASCENDIS PHARMA A/S Call | $9.7m69.4k shares | — |
| IMMUNOMEDICS INC IMMU · Call | $9.5m448.2k shares | — |
| INTRA-CELLULAR THERAPIES INC ITCI · Call | $9.2m267.1k shares | — |
| MADRIGAL PHARMACEUTICALS INC MDGL · Put | $9.1m100.0k shares | — |
| APELLIS PHARMACEUTICALS INC APLS · Put | $8.8m286.9k shares | — |
| INTERCEPT PHARMACEUTICALS IN ICPT · Call | $8.0m64.9k shares | — |
| GLOBAL BLOOD THERAPEUTICS IN GBT · Call | $7.9m100.0k shares | — |
| ZOGENIX INC ZGNX · Put | $7.7m148.2k shares | — |
| CRISPR THERAPEUTICS AG CRSP · Put | $7.5m123.7k shares | — |
| APELLIS PHARMACEUTICALS INC APLS · Call | $7.4m240.3k shares | — |
| INCYTE CORP INCY · Call | $7.0m80.0k shares | — |
| ARQULE INC ARQL · Put | $6.7m336.4k shares | — |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| NEXTCURE INC NXTC · 13G · filed 2026-08-14 | 10.0%≈ $804.3k |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 | 9.9%≈ $704.0k |
| TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 | 9.5%≈ $1.3m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 | 9.0%≈ $1.7m |
| PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 | 7.7%≈ $7.3m |
| CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 | 7.3% |
| CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 | 6.9% |
| LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 | 6.3% |